Mammogen: Funding, Investors & Team (Sep 2026)
Mammogen is a female-led precision health company that is committed to dramatically improving the detection, diagnosis, and treatment of diseases that affect women's health. It also works to build a vibrant global community that supports, empowers, and uplifts women through their entire survivor journey, from beginning to end. With the help of a clinical-stage, patent-pending technology called our flagship genTRU diagnostic programme, we can reliably diagnose breast cancer at all stages of the disease by detecting changes in RNA expression patterns seen in both blood and saliva.
Mammogen has raised $30.0M across 2 funding rounds on record, the most recent a Series A of $30.0M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mammogen Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Mammogen Funding Rounds
Mammogen raised $30k in an undisclosed round announced in Feb 2023.
3.3 years later, a Series A of $30.0M was announced in Jun 2026.
Mammogen Founders and Leadership Team
Contact details for the Mammogen team: 1 of 2 have an email address on file.
Start 14-day free trial →Mammogen Funding Compared to Other Biotechnology Startups
Mammogen's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mammogen in Biotechnology and Aliso Viejo
Companies Similar to Mammogen
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Mammogen Funding FAQs
What does Mammogen do?
Mammogen is a female-led precision health company that is committed to dramatically improving the detection, diagnosis, and treatment of diseases that affect women's health. It also works to build a vibrant global community that supports, empowers, and uplifts women through their entire survivor journey, from beginning to end. With the help of a clinical-stage, patent-pending technology called our flagship genTRU diagnostic programme, we can reliably diagnose breast cancer at all stages of the disease by detecting changes in RNA expression patterns seen in both blood and saliva.
How much funding has Mammogen raised?
Mammogen has raised $30.0M across 2 rounds on record. The most recent is a Series A of $30.0M announced in Jun 2026.
When did Mammogen last raise funding?
Mammogen's most recent funding round on record is a Series A of $30.0M, announced in Jun 2026.
Who founded Mammogen?
FundedIQ lists Elizabeth Cormier (Founder), Marty Keiser (Founder) at Mammogen.
Where is Mammogen headquartered?
Mammogen is based in Aliso Viejo, California, United States.
How many employees does Mammogen have?
Mammogen is in the 1-10 employee band.
How does Mammogen's funding compare to other Biotechnology startups?
Mammogen's latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Mammogen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mammogen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.